Diffuse midline gliomas (DMGs) are some of the most aggressive and deadly childhood brain tumors. These cancers, which mainly ...

A research team has made a major discovery on how the CUL5 gene affects CAR-T cell therapy, an advanced cancer therapy. The study reveals that reducing the activity of the CUL5 gene helps CAR-T cells ...

“This could be an important step toward creating safe and effective allogeneic CAR T cells, which would greatly increase the ...

A study of 783 patients treated with CAR T cell therapy found no evidence that the therapy itself caused secondary cancers.

Within a large group of more than 700 patients treated with CAR T cell therapy, researchers found no evidence that the therapy itself caused any type of secondary cancer in the modified T cells, ...

Scientists rebuild the body's own proteins and fats into nano delivery vans that get genetic medicines to exactly the right ...

Researchers have discovered stem-like T cells, enabled by ID3 protein, that combat immune exhaustion in chronic diseases.

A new advance may make it possible to use off-the-shelf CAR T cells provided by healthy donors. The new approach studied in mice equipped CAR T cells with the viral protein Nef.

For four decades, Ohio State blood and bone marrow transplant innovation has improved cancer care with an increasing emphasis ...

Scientists have progressed from merely provoking an anti-cancer immune response to designing it ...

AdAlta (ASX:1AD) is bringing cellular immunotherapy products from Asian to western markets to drive value creation.

BRANFORD, Conn., Feb. 11, 2025 (GLOBE NEWSWIRE) -- EvolveImmune Therapeutics, an immunotherapy company developing first-in-category, multifunctional T Cell engager biotherapeutics to address unmet ...